Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects

NCT01113320 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Placebo
DRUG: Safinamide

Sponsor

Newron Pharmaceuticals SPA